Intervention Review

Anticholinergics for symptomatic management of Parkinson´s disease

  1. Regina Katzenschlager1,*,
  2. Cristina Sampaio2,
  3. João Costa2,
  4. Andrew Lees3

Editorial Group: Cochrane Movement Disorders Group

Published Online: 22 JUL 2002

Assessed as up-to-date: 4 MAY 2002

DOI: 10.1002/14651858.CD003735

How to Cite

Katzenschlager R, Sampaio C, Costa J, Lees A. Anticholinergics for symptomatic management of Parkinson´s disease. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003735. DOI: 10.1002/14651858.CD003735.

Author Information

  1. 1

    Donauspital/SMZ-Ost, Department of Neurology, Vienna, Austria

  2. 2

    Faculdade de Medicina de Lisboa, Laboratório de Farmacologia Clínica e Terapêutica, Lisboa, Portugal

  3. 3

    University College London, Reta Lila Weston Institute of Neurological Studies, London, UK

*Regina Katzenschlager, Department of Neurology, Donauspital/SMZ-Ost, Langobardenstrasse, 122, Vienna, 1220, Austria.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 JUL 2002


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.